Related Experiment Video
Updated: Feb 5, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study
Fleur Lorton1,2,3, Martin Chalumeau2,4,5, Rémy Assathiany6,7
1Centre d'investigation clinique INSERM 1413, Femme Enfant Adolescent CHU de Nantes, Nantes, France.
Insights
Incomplete childhood vaccinations for meningococcal C and pneumococcal conjugate vaccines are linked to severe infections and deaths. Improving immunization programs could significantly reduce these preventable cases.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Public Health Epidemiology
Background:
- Suboptimal vaccination coverage and rising vaccine hesitancy pose significant public health challenges.
- Meningococcal C and pneumococcal conjugate vaccines are critical for preventing severe childhood infections.
Purpose of the Study:
- To investigate the morbidity and mortality associated with incomplete meningococcal C and pneumococcal conjugate vaccinations in children.
- To quantify the impact of vaccine-preventable infections in a pediatric population.
Main Methods:
- A prospective, observational, population-based study was conducted in a French region from 2009 to 2014.
- Included children aged 1 month to 16 years with community-onset bacterial infections requiring intensive care or resulting in death.
- Defined vaccine-preventable infections based on national vaccine schedules and vaccination status.
Main Results:
- Among 124 children with severe meningococcal or pneumococcal infections, 16% died and 10% had severe sequelae.
- Vaccine-preventable infections accounted for 15% of all infections, 25% of deaths, and 25% of severe sequelae.
- A significant proportion (61%) of eligible children had incomplete meningococcal C and pneumococcal conjugate vaccination schedules.
Conclusions:
- Better implementation of immunization programs could reduce vaccine-preventable meningococcal and pneumococcal infections by approximately 25%.
- Addressing vaccine hesitancy and improving vaccination coverage are crucial for reducing childhood morbidity and mortality.
- Study findings can inform public health strategies to enhance vaccine perception and uptake.
Background:
In a context of suboptimal vaccination coverage and increasing vaccine hesitancy, we aimed to study morbidity and mortality in children related to missing or incomplete meningococcal C and pneumococcal conjugate vaccines.
Methods:
We conducted a prospective, observational, population-based study from 2009 to 2014 in a French administrative area that included all children from age 1 month to 16 years who died before admission or were admitted to an intensive care unit for a community-onset bacterial infection. Vaccine-preventable infection was defined as an infection with an identified serotype included in the national vaccine schedule at the time of infection and occurring in a non- or incompletely vaccinated child. Death and severe sequelae were studied at hospital discharge. Frequencies of vaccine-preventable morbidity and mortality caused by meningococcus and pneumococcus were calculated.
Results:
Among the 124 children with serotyped meningococcal (n = 75) or pneumococcal (n = 49) severe infections included (median age 26 months), 20 (16%) died and 12 (10%) had severe sequelae. Vaccine-preventable infections accounted for 18/124 infections (15%, 95% CI 9, 22), 5/20 deaths (25%, 95% CI 9, 49), and 3/12 severe sequelae cases (25%, 95% CI 0, 54). The vaccine schedule for meningococcal C and pneumococcal conjugate vaccinations was incomplete for 71/116 (61%) children targeted by at least one of these two vaccination programs.
Conclusions:
Mortality and morbidity rates related to vaccine-preventable meningococcal or pneumococcal infection could be reduced by one quarter with better implementation of immunisation programs. Such information could help enhance the perception of vaccine benefits and fight vaccine hesitancy.
More Related Videos
Related Concept Videos
Vaccinations
Conservation of Small Populations
What is Population Genetics?
What are Populations and Communities?
Population Growth
Acute Kidney Injury IV: Diagnostic Studies and Prevention

